These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of the biological activity of uracil mustard and Dopan. PETERING HG; BUSKIRK HH; MUSSER EA; EVANS JS Cancer Chemother Rep; 1963 Mar; 27():1-10. PubMed ID: 13942713 [No Abstract] [Full Text] [Related]
4. [SPECTROPHOTOMETRIC DETERMINATION OF CYTOSTATICS FROM THE DICHLOROETHYLAMINE GROUP (DOPAN AND SARCOLYSIN) IN THE ULTRAVIOLET RANGE]. BLAZHEK IIa; KRACHMAR I Farm Zh; 1965; 20():22-5. PubMed ID: 14348007 [No Abstract] [Full Text] [Related]
5. [A CASE OF ACUTE POISONING WITH DOPAN]. BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983 [No Abstract] [Full Text] [Related]
6. [IMMEDIATE AND REMOTE RESULTS OF THE TREATMENT OF LYMPHOGRANULOMATOSIS WITH DOPAN]. IVANOVA EM Klin Lech Zlokach Novoobraz; 1963; 91():87-90. PubMed ID: 14184304 [No Abstract] [Full Text] [Related]
7. [Pharmacological comparisons on a new antitumor agent: dopan]. MAZZUCCHELLI L Boll Chim Farm; 1962 Aug; 101():630-2. PubMed ID: 13934278 [No Abstract] [Full Text] [Related]
8. [New method of treating patients with rheumatoid arthritis using electrophoresis of the immunosuppressive preparation dopan from a dimexide solution]. Kozlova LA; Tereshina LG Vopr Kurortol Fizioter Lech Fiz Kult; 1986; (1):33-5. PubMed ID: 3518232 [No Abstract] [Full Text] [Related]
9. [Results of dopan therapy of lymphogranulomatosis based on the data of the Khirgizin Scientific Research Institute of Oncology and Radiology]. Sikorskaia IaV Sov Zdravookhr Kirg; 1965; 2():34-8. PubMed ID: 4221039 [No Abstract] [Full Text] [Related]
11. [ON DOPAN (EXPERIMENTAL STUDIES ON DOPAN LABELED WITH C-14)]. KOST EA; KOZYREVA AL Farmakol Toksikol; 1963; 26():729-32. PubMed ID: 14176187 [No Abstract] [Full Text] [Related]
12. DOPAN IN LYMPHOGRANULOMATOSIS. ITS IMMEDIATE AND DISTANT RESULTS. IVANOVA EM Acta Unio Int Contra Cancrum; 1964; 20():375-6. PubMed ID: 14151933 [No Abstract] [Full Text] [Related]
13. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS]. SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614 [No Abstract] [Full Text] [Related]
14. [EXPERIENCE IN THE USE OF THIO-TEPA, DOPAN AND SARCOLYSIN IN THE TREATMENT OF MALIGNANT TUMORS OF THE UPPER RESPIRATORY TRACT AND THE EAR]. SVETLAKOV MI; KRAVCHENKO AA Vestn Otorinolaringol; 1964; 26():49-53. PubMed ID: 14252954 [No Abstract] [Full Text] [Related]
15. Dopan. WHITE FR Cancer Chemother Rep; 1961 Oct; 14():169-73. PubMed ID: 14006515 [No Abstract] [Full Text] [Related]
16. Dopan and related compounds. LARIONOV L Cancer Chemother Rep; 1961 Jun; 12():205-6. PubMed ID: 13759106 [No Abstract] [Full Text] [Related]
17. A method of evaluation of quality of 4-methyl-5-(bis-(beta-chloroethyl)-amino)-uracil. Grabowska I; Kaliszan R; Kuciński W Pol J Pharmacol Pharm; 1973; 25(6):621-6. PubMed ID: 4792485 [No Abstract] [Full Text] [Related]
18. [Qualitative and quantitative analysis of pharmaceutical preparations--derivatives of di-(2-chlorethyl)-amine]. Kozlov NE; Bernshtein VN Farmatsiia; 1970; 19(3):34-5. PubMed ID: 5429690 [No Abstract] [Full Text] [Related]
19. [EXPERIMENTAL CHROMOSOME ALTERATIONS DUE TO CYCLOPHOSPHAMIDE AND URACIL-MUSTARD]. BALLERINI G; BOSI L; PARESCHI PL; PUNTURIERI E Arcisp S Anna Ferrara; 1964; 17():1139-52. PubMed ID: 14265725 [No Abstract] [Full Text] [Related]
20. [Result of use of dopan in treatment of chronic myeloleukosis]. MOKEEVA RA Sov Med; 1958 Sep; 22(9):42-6. PubMed ID: 13615483 [No Abstract] [Full Text] [Related] [Next] [New Search]